News

TRHC’s CareVention HealthCare Partners with Golden Valley Health Centers to Provide Multiple Services to new Central Valley PACE Program

MOORESTOWN, NJ, (August 6, 2020) – Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced it has contracted with Golden Valley Health Centers to provide CareVention HealthCare PACE technology and services for Golden Valley’s newest center and entrée into the PACE market. Named Central Valley PACE, the new center is located in Modesto, California. It will begin enrolling participants September 1, 2020. The Program of All-inclusive... Read More

Tabula Rasa HealthCare Reports Second Quarter 2020 Results

MOORESTOWN, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today reported financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Highlights Total revenue of $76.8 million, which is within our guidance range of $76.0 million to $81.0 million for the second quarter of 2020, was up 1% as compared to the second quarter of 2019.... Read More

Tabula Rasa HealthCare Launches MedWise™ SaaS Technology Integration for Community Pharmacists

MOORESTOWN, NJ, (July 15, 2020) – Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced the launch of MedWise™ to its PrescribeWellness® (PW) community pharmacy network. Compared to the current technology of one-to-one drug interaction checking that has existed for decades in electronic health records and pharmacy software, MedWise, for use by pharmacists, is the only technology that cumulatively compares how medications interact together, all at... Read More

Tabula Rasa HealthCare’s Risk Adjustment Division Launches New Online Training for Physicians and Other Providers

Moorestown, NJ, June 29, 2020 — Tabula Rasa HealthCare ®(TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, has launched the “Clinical Documentation Excellence” (CDE) Online Education series for Medicare risk adjustment. The program is designed for physicians, physician assistants, nurse practitioners, and other clinicians who offer services in value-based care settings, including Programs of All-inclusive Care for the Elderly (PACE), Medicare Advantage, managed Medicaid, and Accountable Care Organizations. “Optimizing risk adjustment... Read More

Tabula Rasa HealthCare® Expands Clinical Services for Patients Enrolled in Medicare Advantage

Moorestown, NJ, June 25, 2020 – Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced it is expanding its clinical services to include special needs and high-risk patient populations enrolled in Medicare Advantage. TRHC will assist health plans in meeting the Care for Older Adults (COA) program requirements. Starting with a large multi-state health plan, TRHC’s SinfoniaRx® solution will begin providing medication reviews and pain assessments... Read More

TRHC and Equiscript Launch an Advanced Medication Adherence Reporting and Analytics Program

Moorestown, NJ, JUNE 16, 2020 – Tabula Rasa HealthCare® Corporation (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety has partnered with Equiscript, a 340B patient pharmacy care and technology company, to deliver advanced medication adherence reports and analytics for Equiscript and its community health center and hospital clients. “A Medication Safety Review™ is the most important step in setting a patient’s foundation for an optimized medication regimen,” said TRHC Chairman and... Read More

Regence and TRHC Partner on COVID-19 Virtual Clinical Trial to Assess Proposed Treatment Risks

Moorestown, NJ, June 9, 2020 – Regence and Tabula Rasa HealthCare® (NASDAQ: TRHC) announced today that the companies have partnered on a virtual clinical trial to assess the risk of adverse drug events (ADEs) associated with drugs repurposed for the treatment of COVID-19. The trial examines de-identified medical information for approximately 500,000 Regence health plan members across multiple lines of business. Regence is a family of health plans in Oregon, Idaho, Utah and select counties... Read More

A Message from Tabula Rasa HealthCare

June 5, 2020 Recently, we have seen the overwhelming pain and hurt wrapped in those heart-wrenching cries for help: ‘I can’t breathe. Please stop. I can’t breathe.’ Systemic racism is another ‘virus’ that we must address. George Floyd, Ahmaud Arbery, and Breonna Taylor are just three names in a span of generations of untimely and unjust deaths. As we witnessed the heartbreak across America, especially in our communities of color, we will not pretend to... Read More